Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | |
| Sales | 619 | 683 |
| Cost of Goods | 68 | 79 |
| Gross Profit | 551 | 604 |
| Operating Expenses | 1,822 | 1,352 |
| Operating Income | -1,203 | -670 |
| Interest Expense | 702 | 907 |
| Other Income | -175 | 60 |
| Pre-tax Income | -2,080 | -1,517 |
| Net Income Continuous | -2,080 | -1,517 |
| Net Income | $-2,080 | $-1,517 |
| EPS Basic Total Ops | -1.14 | -0.87 |
| EPS Basic Continuous Ops | -1.05 | -0.77 |
| EPS Diluted Total Ops | -1.14 | -0.87 |
| EPS Diluted Continuous Ops | -1.05 | -0.77 |
| EBITDA(a) | $-1,179 | $-670 |